UC Berkeley look to subpoena George Church as part of on-going CRISPR patent dispute
New start-up companies are constantly commercialising new technologies and services. Genomics is ripe for investment right now.
Scientists have begun to move into the £650 million Francis Crick Institiute in London and take up residence in their new labs
Precision medicine put to the test: UnDx Consortium gathers to examine new hypotheses for undiagnosed patients
Consortium gathers in San Diego to create new paths to identifying currently undiagnosed illnesses
Apple’s Senior Vice President of Worldwide Marketing joins Illumina on the Board of Directors
How can consumers learn more about their genome while still having complete control of their data?
“We’re betting on DNA becoming an integrated part of many aspects of bettering ourselves” – Robin Thurston, Helix
The new CEO at Helix gave us his take on creating the world’s first personal genomics platform